In response to COVID-19, many clinics provided medication abortion using history-based screening alone, forgoing ultrasounds. This JAMA Internal Medicine Study found that 95% of these medication abortions were completed without requiring additional medical intervention. It concludes that screening for medication abortion based on history alone is effective and safe.
Upadhyay, Ushma D., Raymond, Elizabeth G., Koenig, Leah R., “Outcomes and Safety of History-Based Screening for Medication Abortion.” JAMA Intern Med. 2022;182(5):482-491. doi:10.1001/jamainternmed.2022.0217
During COVID-19 Emergency (currently in place) the FDA will not require a qualified healthcare provider to dispense mifepristone in-person but allow clinics to distribute the medicine via mail receipt (April 12, 2021) https://www.acog.org/news/news-releases/2021/04/acog-applauds-fda-action-on-mifepristone-access-during-covid-19-pandemic
See also, ACLU, FDA Respond to ACOG April 2021, https://www.aclu.org/letter/fda-response-acog-april-2021; D’Amrosio, A. “FDA Temporarily Lifts Restriction on Abortion Pill.” MEDPAGE TODAY, April 2021, https://www.medpagetoday.com/obgyn/generalobgyn/92077
See also: The Availability and Use of Medication Abortion, Women’s Health Policy, Kaiser Family Foundation. June 2021. KFF https://www.kff.org/womens-health-policy/fact-sheet/the-availability-and-use-of-medication-abortion/
TelAbortion (research project)
Since 2016, Gynuity Health Project TelAbortion Study is operating in 15 states and the District of Columbia. “The TelAbortion Study is a research project that aims to evaluate the use of telemedicine for providing a medical abortion to those who prefer to receive the abortion pills in the mail.” The medications used are FDA approved.
TelAbortion. “TelAbortion: About the Project.” Gynuity Health Projects, https://telabortion.org/about.
Upadhyay, Ushma D., et al. “Adoption of no-test and telehealth medication abortion care among independent abortion providers in response to COVID-19☆.” Contraception: X, vol. 2: 100049, 2020, https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7718446/.
Telemedicine During the Pandemic
Contraception, Volume 104, Issue 1: Pages 43-48, Erica Chong et al, sciencedirect.com/science/article/pii/S0010782421000913Pdf:Expansion of a direct-to-patient telemedicine abortion service in the United States and experience during the COVID-19 pandemic, available at; https://www.sciencedirect.com/journal/contraception